Symbol="ADAG"
AssetType="Common Stock"
Name="Adagene Inc"
Description="Adagene Inc., a clinical-stage biopharmaceutical company, is dedicated to the research, development, and production of monoclonal antibody drugs for cancer. The company is headquartered in Suzhou, China."
CIK="1818838"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4F, BUILDING C14, NO. 218, XINGHU STREET, SUZHOU INDUSTRIAL PARK, JIANGSU, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="58218000"
EBITDA="-82471152"
PERatio="None"
PEGRatio="None"
BookValue="1.933"
DividendPerShare="0"
DividendYield="0"
EPS="-1.68"
RevenuePerShareTTM="0.215"
ProfitMargin="0"
OperatingMarginTTM="-9.03"
ReturnOnAssetsTTM="-0.307"
ReturnOnEquityTTM="-0.667"
RevenueTTM="9292700"
GrossProfitTTM="10175300"
DilutedEPSTTM="-1.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.391"
AnalystTargetPrice="12.53"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.499"
PriceToBookRatio="0.433"
EVToRevenue="0.0853"
EVToEBITDA="1.262"
Beta="0.204"
num_52WeekHigh="2.1"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.394"
num_200DayMovingAverage="1.406"
SharesOutstanding="43772700"
DividendDate="None"
ExDividendDate="None"
symbol="ADAG"
open="1.45"
high="1.45"
low="1.32"
price="1.37"
volume="18405.00"
latest_trading_day="2023-07-21"
previous_close="1.33"
change="0.04"
change_percent="3.0075%"
aroon_positive_momentum_days="40"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="20366"
Change_recent_avg="-0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.76"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="1156"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_negative_thumbnail_id_2="1134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="698"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_positive_thumbnail_id_2="990"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
